tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ADPT is currently covered by 5 analysts with an average price target of $9.86. This is a potential upside of $2.85 (40.66%) from yesterday's end of day stock price of $7.01.
Adaptive Biotechnologies Corp's activity chart (see below) currently has 30 price targets and 38 ratings on display. The stock rating distribution of ADPT is 33.33% HOLD and 66.67% BUY.
Analysts average stock forecasts to be materialized ratio is 60.63% with an average time for these price targets to be met of 80.63 days.
Highest price target for ADPT is $11, Lowest price target is $6, average price target is $9.
Most recent stock forecast was given by SALVEEN RICHTER from GOLDMAN SACHS on 21-Mar-2025. First documented stock forecast 22-Jul-2019.
Currently out of the existing stock ratings of ADPT, 5 are a HOLD (33.33%), 10 are a BUY (66.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$9
$1.67 (22.78%)
$7.5
1 months 2 days ago
(21-Mar-2025)
3/5 (60%)
$0.6 (7.14%)
144
Buy
$11
$3.67 (50.07%)
$7
2 months 3 days ago
(20-Feb-2025)
7/12 (58.33%)
$2.63 (31.42%)
100
Buy
$9
$1.67 (22.78%)
$8
4 months 5 days ago
(18-Dec-2024)
4/8 (50%)
$3.03 (50.75%)
101
Buy
$6
$-1.33 (-18.14%)
$8
8 months 21 days ago
(02-Aug-2024)
2/2 (100%)
$1.7 (39.53%)
222
Hold
$10
$2.67 (36.43%)
$13
1 years 5 months 30 days ago
(24-Oct-2023)
1/6 (16.67%)
$5.31 (113.22%)
5
What is ADPT (Adaptive Biotechnologies Corp) average time for price targets to be met?
Which analyst has the current highest performing score on ADPT (Adaptive Biotechnologies Corp) with a proven track record?
Which analyst has the current lower performing score on ADPT (Adaptive Biotechnologies Corp) with a proven track record?
Which analyst has the most public recommendations on ADPT (Adaptive Biotechnologies Corp)?
Which analyst is the currently most bullish on ADPT (Adaptive Biotechnologies Corp)?
Which analyst is the currently most reserved on ADPT (Adaptive Biotechnologies Corp)?
